NewAmsterdam Pharma Company N.V. (NAMS) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for NewAmsterdam Pharma Company N.V., updated every trading day.
Health Care · Biotechnology: Pharmaceutical Preparations
Price
$21.07
+2.78% today
Market cap
$2.5B
Overall quality
—
Kronos AI 30-day
+35.6%
8 of 8 simulated paths end higher
NewAmsterdam Pharma Company N.V. (NAMS) is a Health Care company in Biotechnology: Pharmaceutical Preparations, worth $2.5B. It trades at $21.07, up 2.78% today. 10 analysts' average target of $53.00 implies +151.5% from today's price. Kronos AI's 30-day forecast is +35.6% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $53.00 |
| Low – high | $42.00 – $60.00 |
| Analysts | 10 |
| Upside to average | +151.5% |
Kronos AI 30-day forecast
| Expected close | $27.80 (+35.6%) |
| Likely range | +31.1% … +47.9% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
Not scored: the financial data for this listing is incomplete.
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Halal Health Care stocks · Zakat calculator · Purification calculator
Similar companies in Biotechnology: Pharmaceutical Preparations
For information only, not investment advice. Prices updated: 2026-10-29.